Positron emission tomography - detection of positrons emitted during the decay of a radionuclide that has been injected into a patient, most frequently using 2-[18F] fluoro-2-deoxy-D-glucose (FDG), revealing differences in regional glucose activity among normal and pathologic brain structures, used primarily for the detection of extracranial metastatic disease and Alzheimer's disease